A CRISPR-based gene editing therapy dramatically reduced levels of LDL cholesterol and triglycerides in patients with heart ...
An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...
Data presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions 2025- -Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback